Corvus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Corvus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Corvus Pharmaceuticals Inc
Rating: 1.48758325
Author: Trendlyne DVM scores

about

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad ...

13.18 -0.57 (-4.15%)

51.09% Fall from 52W High

830.6K

XNAS Volume

XNAS 24 Mar, 2026 3:42 PM (EDT)

Board Meeting

The next board meeting for Corvus Pharma Inc is on 25 Mar 2026 for the purpose of Corvus Pharmaceuticals Inc Fourth Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

1.8 / 100

Technically Neutral

57.7 / 100

No estimates available

Corvus Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Corvus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad ...

51.09% Fall from 52W High

SWOT Analysis

Corvus Pharma Inc Live Price Chart